Not Yet RecruitingNCT06547450
Official study titleStudy of the Cost-efficacy and Acceptability of the Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain (PU-AP)
This study isn't recruiting yet.
In VillarrealDepression, AnxietyBehavioural studyAges 18+
- Countries
- Spain
- Sponsor
- Instituto de Investigación Sanitaria Aragón
Not Yet RecruitingNCT07311668
Official study titleAccuracy of an Artificial Intelligence-Based System for Diagnosing Depressive Disorders: A Paired Comparison With Psychiatrist Clinical Diagnoses
This study isn't recruiting yet.
In ShanghaiDepressionObservational studyAges 18–60
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
Not Yet RecruitingNCT06768801
Official study titlePilot RCT of the Web-app Based Lifestyle Physical Activity Promotion Program (WPAPP) for Middle Aged Latinas
This study isn't recruiting yet.
Remote / onlineDepressionBehavioural studyAges 40–60
- Countries
- Sponsor
- University of Texas at Austin
CompletedNCT07059143
Official study titleA Multicenter Randomized Double-Blind Controlled Trial of Six-Week Transcranial Temporal Interference Stimulation(TIS) Targeting the Right Amygdala for Rapid Alleviation of Depressive Symptoms.
This study has finished and is no longer accepting participants.
Multiple locations, including GuangdongDepressionDevice studyAges 18–60
- Countries
- China
- Sponsor
- Ruijin Hospital
CompletedNCT01344733
Official study titleA Non - Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient Diagnosed as With Treatment Resistant Major Depressive Disorder (MDD)
This study has finished and is no longer accepting participants.
Multiple locations, including AgrigentoDepression, BipolarityObservational studyAges 18–65
- Countries
- Italy
- Sponsor
- AstraZeneca
CompletedNCT07549581
Official study titleA Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of SEP-380135 in Adults With Schizophrenia or With a Major Depressive Episode Associated With Bipolar I or II Disorder or Major Depressive Disorder
This study has finished and is no longer accepting participants.
In Los AlamitosDepression, Schizophrenia, ...Medication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
WithdrawnNCT06735079
Official study titleA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 As Adjunctive Treatment for Major Depressive Disorder (MDD)
This study was withdrawn before enrollment.
Multiple locations, including MilanDepressionMedication studyAges 18–65
- Countries
- Switzerland, Italy
- Sponsor
- MGGM LLC
Enrolling By InvitationNCT07653113
Official study titleAdjunctive Resonance-Based Chinese Five-Element Music Intervention for Depressive Disorders and Anxiety Symptoms in Male Inpatients: A Randomised Controlled Trial
This study is by invitation only.
In ShanxiDepression, AnxietyPlacebo comparisonAges 18–44
- Countries
- China
- Sponsor
- University of Malaya
CompletedNCT02051413
Official study titleBeta-arrestins and Response to Venlafaxine in Major Depressive Disorder
This study has finished and is no longer accepting participants.
In Le Kremlin-BicêtreDepressionMedication studyAges 18–65
- Countries
- France
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
Enrolling By InvitationNCT07363980
This study is by invitation only.
Multiple locations, including AarhusDepression, AnxietyObservational studyAges 50–75
- Countries
- Denmark
- Sponsor
- Ellen Margrethe Hauge
CompletedNCT07253207
What is this study about?This study evaluated the safety and effectiveness of Levomilnacipran Hydrochloride Extended-Release Capsules for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including HefeiDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
UnknownNCT06385405
Official study titleRepetitive Transcranial Magnetic Stimulation(rTMS) Treatment Based on Personalized Modulation of Electroencephalography Promotes Symptom Remission in Major Depressive Disorder (MDD) - A Randomized Controlled Clinical Trial
Current recruitment status is unconfirmed.
In ShanghaiDepressionDevice studyAges 16–65
- Countries
- China
- Sponsor
- Shanghai Mental Health Center